Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
The cardiac monitor continuously shows the cardiac rhythm and sends the electrocardiogram (EKG) tracing to a main monitor in the nursing station. Most commonly used in emergency rooms and critical care areas, cardiac monitoring allows for continual observation of several patients. Aside from monitoring cardiac patients, continuous monitoring is useful for observation of postoperative patients, patients with severe electrolyte imbalances, and other unstable patients. Continuous cardiac monitoring allows for prompt identification and initiation of treatment for cardiac arrhythmias and other conditions.
Increasing incidence of cardiac vascular diseases (CVDs) and rise in demand of accurate diagnosis in healthcare sector are boosting cardiac monitoring devices market globally. Moreover, increase in ageing population and lifestyle changes leading to hypertension, obesity, and other risk factors that lead to vascular disorders are significantly contributing towards the growth of the market. To provide better treatment, governments offer reimbursement plan, which can cover the treatment cost. This will lead most of the people to opt for early treatment plan such as angiography. This, in turn, will drive the global angiography catheters market during the forecast period. However, dearth of skilled professionals with expertise in electrocardiography and cardiac rhythm management devices is hampering the market growth.
The report analyses the global cardiac monitoring devices market based on product, type, end user and geography.
The cardiac monitoring devices market is categorized into various products such as defibrillators including implantable cardioverter defibrillators and external defibrillators; and pacemakers such as implantable pacemakers and external pacemakers. The implantable cardioverter defibrillators majorly include transvenous implantable cardioverter defibrillators and subcutaneous implantable cardioverter defibrillators. whereas, the external defibrillators consist of automated external defibrillators, manual external defibrillators and wearable cardioverter defibrillators.
Various types of the cardiac monitoring devices market comprise of ECG devices including resting ECG systems, stress ECG systems and holter monitors; implantable loop recorders; cardiac output monitors including minimally invasive COM devices and noninvasive COM devices; event monitors such as pre-symptom (memory loop) and post symptom event monitor; mobile cardiac telemetry monitoring MCT/MCOT); and smart wearable ECG monitors. Implantable cardiac monitors (ICM) are small electrophysiology (EP) devices that used for long-term monitoring of a patient’s heart electrical activity to detect arrhythmias. The technology can eliminate the need for a bulk external Holter monitor that requires wire leads attached to the patient. Implantable cardioverter defibrillators (ICDs) are useful in preventing sudden death in patients with known, sustained ventricular tachycardia or fibrillation. Newer-generation ICDs may have a dual function which includes the ability to serve as a pacemaker.
The end user of this market are hospitals, home care setting, ambulatory care settings and other end users. Overall, patients prefer less invasive outpatient procedures that can be performed in doctor’s office, instead of hospital procedures that would potentially require general anaesthesia. Non-invasive treatments for cardiac monitoring are capitalizing on this trend and represent the fastest-growing market worldwide.
By geography, the global cardiac monitoring devices market is studied across the countries of key regions such as, North America, Europe, Asia Pacific and rest of the world regions which includes Latin America, and Middle East & Africa. In 2018, North America dominated the market owing to factors such as technological innovations, increasing healthcare spending, and swelling government initiatives to create awareness regarding cardiac health. According to the American Heart Association (AHA), 2017, about 92.1 million adults in the U.S. are suffering from some form of cardiovascular disease or the after-effects of stroke. Moreover, Asia-Pacific cardiac monitoring devices market is expected to grow at the fastest CAGR due to rising government initiatives for the modernization of healthcare infrastructure, large population base and growing incidence of cardiac diseases. According to the Japanese Heart Rhythm Society in 2017, the Asian population with atrial fibrillation (AF) is estimated to reach 72 million by 2050, of whom 2.9 million may suffer from AF-associated strokes.
The leading market players of the global cardiac monitoring devices market are Abbott Laboratories, Applied Cardiac System, Biotelemetry, Biotronik, Boston Scientific, Cardiac Science (Aurora Capital Group), GE Healthcare, Hill-Rom Holdings, Livanova, Medtronic PLC, Philips Healthcare and Schiller. In March 2017, Medtronic plc announced U.S. Food and Drug Administration (FDA) 510(k) clearance for its Reveal LINQ Insertable Cardiac Monitor (ICM) with TruRhythm Detection, an advanced cardiac monitor offering improved accuracy to better identify abnormal heartbeats.
The global cardiac monitoring devices market is segmented based on product, type, end user and geography. The cardiac monitoring devices market is categorized into various products such as defibrillators including implantable cardioverter defibrillators and external defibrillators; and pacemakers such as implantable pacemakers and external pacemakers.
Various types of the cardiac monitoring devices market comprise of ECG devices including resting ECG systems, stress ECG systems and holter monitors; implantable loop recorders; cardiac output monitors including minimally invasive COM devices and noninvasive COM devices; event monitors such as pre-symptom (memory loop) and post symptom event monitor; mobile cardiac telemetry monitoring MCT/MCOT); and smart wearable ECG monitors.
The end user of this market are hospitals, home care setting, ambulatory care settings and other end users. Overall, patients prefer less invasive outpatient procedures that can be performed in doctor’s office, instead of hospital procedures that would potentially require general anaesthesia.
By geography, the global cardiac monitoring devices market is studied across the countries of key regions such as, North America, Europe, Asia Pacific and rest of the world regions which includes Latin America, and Middle East & Africa. In 2018, North America dominated the market owing to factors such as technological innovations, increasing healthcare spending, and swelling government initiatives to create awareness regarding cardiac health.
Why to buy this report:
